HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma
Open Access
- 14 May 2002
- Vol. 94 (10), 2669-2674
- https://doi.org/10.1002/cncr.10531
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- HER2 status in non-small cell lung cancer (NSCLC): results from the patient screening for enrolment to a phase 2 study of herceptinEuropean Journal Of Cancer, 2001
- Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?American Journal of Respiratory and Critical Care Medicine, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Serum Level and Tissue Expression of c-erbB-2 Protein in Lung AdenocarcinomaChest, 1995
- C-erbB-2 immunostaining: problems with interpretation.Journal of Clinical Pathology, 1994
- Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.Journal of Clinical Pathology, 1994
- Correlation of Intrinsic Chemoresistance of Non-Small-Cell Lung Cancer Cell Lines With HER-2/neu Gene Expression but Not With ras Gene MutationsJNCI Journal of the National Cancer Institute, 1993
- Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancerMolecular Carcinogenesis, 1992
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Lack of C-erbB-2 protein expression in pulmonary carcinoid tumours.Journal of Clinical Pathology, 1991